Stay informed with the latest updates for the inheritable blood disorders community. Industry FDA Approves NovoSeven® RT for Glanzmann’s ThrombastheniaJul 14, 2014 Industry Bayer and Dimension Partner to Develop Novel Hemophilia A Gene TherapyJun 30, 2014 Industry FDA Approves Biogen’s ELOCTATE™ for Hemophilia AJun 11, 2014 Industry CSL Study Data Show Longer Intervals Between FIX InfusionsJun 2, 2014 Industry Novo Nordisk Presents NovoEight® Data at WFH CongressJun 1, 2014 Industry Biogen and Sobi Announce Factor Donations at WFH CongressJun 1, 2014 Industry Bayer Announces 2014 BHAP WinnersJun 1, 2014 Industry Baxter Highlights Pipeline Products at WFH CongressJun 1, 2014 Industry Bayer’s Kogenate®FS Approved for Adult ProphylaxisJun 1, 2014 Industry Baxter Announces Phase 3 Study Data for rVWF TherapyMay 1, 2014 Industry Biogen Announces Longer-Acting FVIII Study Results in KidsMay 1, 2014 IndustryNovo Nordisk Reports Results of Long-Acting rVIII ProductApr 1, 2014 IndustryBayer Reports Progress for Longer-Acting rFVIII ProductMar 1, 2014 IndustryFDA Grants Breakthrough Designation for Bristol-Myers Squibb Oral HCV…Mar 1, 2014 IndustryGilead Files NDA for HCV Combination TherapyMar 1, 2014 Pagination First page Previous page … Page 12 Page 13 Page 14 Page 15 Current page 16 Page 17 Page 18 Page 19 Page 20 … Next page Last page
